本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Tiziana Life Sciences PLC

1.57
+0.09006.08%
盘后1.620.0500+3.18%18:46 EDT
成交量:37.72万
成交额:58.92万
市值:1.63亿
市盈率:-11.77
高:1.60
开:1.56
低:1.50
收:1.48
数据加载中...
2024/05/10

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/06/14

[修订]年度报告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2023/04/26

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/05/23

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/05/04

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/03/01

SEC问询函

CORRESP [Cover] - Correspondence
2022/01/04

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/10/20

交易所摘牌声明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2021/05/17

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/26

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/08/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/17

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/04/14

非美公司披露报告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/09

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/01

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]